Brief: Mereo Biopharma Reports Interim Financial Results For The Six Months Ended June 30, 2023
07/09/2023 13:43
Sept 7 (Reuters) - Mereo Biopharma Group PLC MAH0y.F :
* MEREO BIOPHARMA REPORTS INTERIM FINANCIAL RESULTS FOR THE
SIX
MONTHS ENDED JUNE 30, 2023 AND PROVIDES CORPORATE UPDATE
* MEREO BIOPHARMA GROUP PLC - CONTINUE TO EXPECT THAT WE
HAVE
SUFFICIENT RUNWAY TO FUND OPERATIONS INTO 2026
Source text for Eikon: ID:nGNX7dF6Bw
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand